Structural Entry Filters:

Search Count: 9

4YDM image
High Resolution Crystal Structure Of Human Transthyretin Bound To Ligand And Conjugates Of 3-(5-(3,5-Dichloro-4-Hydroxyphenyl)-1,3,4-Oxadiazol-2-Yl)Phenyl Fluorosulfate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.25 Å Release Date: 2015-07-15
Classification: TRANSPORT PROTEIN
Ligands: 4AJ

4YDN image
High Resolution Crystal Structure Of Human Transthyretin Bound To Ligand And Conjugates Of 4-(5-(3,5-Dichloro-4-Hydroxyphenyl)-1,3,4-Oxadiazol-2-Yl)Phenyl Fluorosulfate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.35 Å Release Date: 2015-07-15
Classification: TRANSPORT PROTEIN
Ligands: 2WN, 4B8

4L1S image
Covalent Modification Of Transthyretin K15 By Yielding The Fluorescent Conjugate (E)-3-(Dimethylamino)-5-(4-Hydroxy-3,5-Dimethylstyryl)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.50 Å Release Date: 2013-10-02
Classification: TRANSPORT PROTEIN
Ligands: 1W4

4L1T image
Transthyretin In Complex With (E)-3-(Dimethylamino)-5-(4-Hydroxy-3,5-Dimethylstyryl)Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.16 Å Release Date: 2013-10-02
Classification: TRANSPORT PROTEIN
Ligands: 1WZ

4HIQ image
The Structure Of V122I Mutant Transthyretin In Complex With Ag10
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.18 Å Release Date: 2013-06-05
Classification: HORMONE BINDING PROTEIN/INHIBITOR
Ligands: 16V

4HIS image
The Structure Of V122I Mutant Transthyretin In Complex With Tafamidis
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.20 Å Release Date: 2013-06-05
Classification: HORMONE BINDING PROTEIN/INHIBITOR
Ligands: 3MI

4FI6 image
Kinetic Stabilization Of Transthyretin Through Covalent Modification Of K15 By 3-(5-(3,5-Dichlorophenyl)-1,3,4-Oxadiazol-2-Yl)-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.46 Å Release Date: 2013-02-20
Classification: HORMONE/HORMONE INHIBITOR
Ligands: 0U7

4FI7 image
Kinetic Stabilization Of Transthyretin Through Covalent Modification Of K15 By 3-(5-(3,5-Dichloro-4-Hydroxyphenyl)-1,3,4-Oxadiazol-2-Yl)-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.40 Å Release Date: 2013-02-20
Classification: HORMONE/HORMONE INHIBITOR
Ligands: 0UA

4FI8 image
Kinetic Stabilization Of Transthyretin Through Covalent Modification Of K15 By 4-Bromo-3-(5-(3,5-Dichloro-4-Hydroxyphenyl)-1,3,4-Oxadiazol-2-Yl)-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.22 Å Release Date: 2013-02-20
Classification: HORMONE/HORMONE INHIBITOR
Ligands: 0UC
Protein Functional Filters: